Het onderzoek

The Pfizer Clinical Research Unit (PCRU) in Brussels is currently testing a new medication, which is being investigated to treat people with achondroplasia.

The main objective of this clinical study is to see how the medication is tolerated by healthy participants.

You may be eligible if:

  • Your four biological Japanese grandparents were born in Japan.
  • You are a healthy male.
  • or You are a healthy female (unable to have children).
  • You are between 21 and 55 years old
  • You are able to comply with all study visits in Brussels

Periode

Your participation in this study could last approximately 9 weeks

Vergoeding

We offer:

  • A financial compensation of 2885,00€ for your time
  • A compensation for your travel costs

Overige informatie

Note: you may be eligible if your four biological Japanese grandparents were born in Japan.

Meer informatie